DRUG · Unmapped registry intervention
Disitamab vedotin
Find medicine records ·
Find other trials using this name
Clinical trial
A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer
NCT06966453
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedA Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer
Design: INTERVENTIONAL · Status: ACTIVE NOT RECRUITING · Phase: PHASE1, PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Breast Cancerverified · MONDO: breast cancer
Breast Neoplasmsunresolved
Interventions
Sponsors & collaborators
Pfizerlead sponsor
Mapped research locations
DallasTexas, United States5AtlantaGeorgia, United States4New HavenConnecticut, United States4Los AngelesCalifornia, United States3MiamiFlorida, United States3Palo AltoCalifornia, United States3San AntonioTexas, United States2NashvilleTennessee, United States2SeattleWashington, United States2Washington D.C.District of Columbia, United States2Colorado SpringsColorado, United States2St. PetersburgFlorida, United States2
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06966453 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.